Latest Posts
About This Stock
More About This Stock
Read
Read
Read
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
Article By:
Lorimer Wilson
Monday, March 4, 2024 12:41 AM EDT
Grand View Research says the global "AI in drug discovery" market should expand at a CAGR of 30% between now, and 2030 which Morgan Stanley believes will lead to 50 novel therapies over the next decade, with annual sales in excess of $50 billion.
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
Article By:
Lorimer Wilson
Monday, February 19, 2024 12:05 AM EDT
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.
Top Picks 2024: Exscientia Plc
Article By:
MoneyShow.com
Sunday, December 31, 2023 10:20 AM EDT
Founded in 2012 and based in Oxford, England, Exscientia Plc is using Artificial Intelligence to develop new medicines and is attracting high-quality partners. It has a rapidly growing pipeline of more than 25 projects in motion.
In this article: EXAI